Assessment of Accuracy, Precision, and Feasibility of CEREBO® - a NearInfrared Light Device to detect and categorize the intracranial hematoma in patientswith suspected brain injury compared to head CT scan as the gold standard:Aprospective Study

Traumatic Brain Injury (TBI) is the leading cause of death and disability across the globe. Time from injury to treatment is the most critical factor that determines the patient’s recovery. Mild TBI with no apparent symptoms are often left undiagnosed, thus delaying the treatment and hence recovery. This observational prospective study determines the efficacy of CEREBO® to detect the intracranial hematoma in comparison with the head CT scan. CEREBO®is a non-invasive, rapid, near-infrared based, point-of-care device. The study also aims to categorise the hematoma based on the bleed volume and depth. Early intracranial hemorrhage detection can help in the patient triaging thus increasing the chances of survival.